FDA Watch: Agency Clears the Way for Approval of Blood-Based PSA Test

FDA Watch: Agency Clears the Way for Approval of Blood-Based PSA Test

The U.S. Preventive Services Task Force (USPTF) recommends that men age 55 to 65 consider prostate cancer screening. The reason it doesn’t directly recommend testing for all men in this age group is that current screening methods that rely on detecting high levels of

This content is for Paid Members only.
Register
Already a member? Log in here